Lucas Silva is Head of Analytical Development and Life Cycle Management at Nanopharm. He has over 7 years of experience in the pharmaceutical industry, from analytical services to formulation technology to drug delivery devices, mostly in the research and development space focused on orally inhaled and nasal drug products. His key research areas are the development of clinically relevant analytical methods, the application of specialized in vitro performance data to de-risk and accelerate drug product development.